Table 1.

Summary of pre- and postoperative hormone levels

	Reference range	Baseline before surgery		Postoperative follow-up data
		11 weeks	2 weeks	4 weeks	8 weeks	15 weeks**
Free T3, pg/mL	1.68–3.67	NA	2.37	2.32	2.01	NA
Free T4, ng/dL	0.70–1.48	NA	0.80	0.96	0.87	NA
TSH, μU/mL	0.35–4.94	1.026	0.940	0.622	1.470	NA
PRL, ng/mL	4.91–29.32	44.3	29.8	6.0	9.1	12.6
GH, ng/mL	0.13–9.88	NA	0.52	0.99	2.69	1.03
IGF-1, ng/mL	115–277	NA	84	66	84	77
ACTH, pg/mL	7.2–63.3	NA	15.1	4.8	7.7	16.1
Cortisol, μg/dL	7.07–19.6	NA	7.1	4.9	5.9	6.7
DHEA-S, μg/dL	58–327	NA	122	119	94	114
LH, mIU/mL		0.7	0.4	2.2	6.8	3.2
Follicular	2.4–12.6
Mid-cycle peak	14.0–95.6
Luteal	1.0–11.4
Postmenopausal	7.7–58.5
FSH, mIU/mL		8.4	8.8	8.3	6.9	3.4
Follicular	3.5–12.5
Mid-cycle peak	4.7–21.5
Luteal	1.7–7.7
Postmenopausal	25.8–134.8
Estradiol, pg/mL		494	245	15	81	184
Follicular	19–226
Mid-cycle peak	49–487
Luteal	78–252
Postmenopausal	≤39
Progesterone, ng/mL		1.1	0.3	<0.1	0.1	11.8
Follicular	≤0.4
Mid-cycle peak	≤3.7
Luteal	8.5–21.9
Total testosterone, ng/mL	0.06–0.86	0.19	0.19	0.15	0.22	NA
Inhibin B, pg/mL	35.6–139.1*	NA	281.4	12.1	NA	NA

^*Reference interval was adopted from Wen et al. (14); ^**Luteal phase.

ACTH, adrenocorticotropic hormone; DHEA-S, dehydroepiandrosterone sulfate; FSH, follicle-stimulating hormone; GH, growth hormone; IGF-1, insulin-like growth factor-1; LH, luteinizing hormone; NA, not available; PRL, prolactin; T3, triiodothyronine; T4, tetraiodothyronine; TSH, thyroid-stimulating hormone.